Trent Dondero

Rheumatologist


 1660 S Columbian Way, Seattle
    Washington, 98108-1532

  206-762-1010    Maps & Directions
Trent Dondero is a Seattle, Washington based rheumatologist who is specialized in Rheumatology. Active license number of Trent Dondero for Rheumatology is MD61152924 in Washington.
Trent Dondero treat joint disease similar to orthopedists but do not perform surgeries. He diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Trent Dondero speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Specialization: Rheumatology
Gender:Male
Practice Address:1660 S Columbian Way, Seattle,
Washington, 98108-1532
Phone:206-762-1010
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1235660424
NPI Enumeration Date: 21 Mar, 2017
NPI Last Update On: 14 Apr, 2025
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Trent Dondero are as mentioned below.
License NumberSpecializationStateStatus
MD61152924Rheumatologist WashingtonPrimary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 4150 V St, #1100
Sacramento, California
Zip: 95817-1460
Phone Number: 916-734-2737
Patients can reach Trent Dondero at 1660 S Columbian Way, Seattle, Washington or can call to book an appointment on 206-762-1010. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 October, 2025.

Comments/ Reviews: